To determine whether Vps18 deficiency promotes tumor development by enhancing EGFR signaling, we investigated whether expressing dominant negative EGFR (dnEGFR) could suppress the lung tumor-promoting phenotype caused by Vps18 loss. Here, EGFR is linked to neoplasm.